TRx 0237
TRx 0237, also called LMT-X or Methylene Blue, is a second-generation tau protein aggregation inhibitor currently in development for the treatment of Alzheimer's disease (AD) and frontotemporal dementia.
| Supplier | BOC Sciences |
|---|---|
| Product # | 613-11-6 |
| Pricing | Inquire |
| Cas | 613-11-6 |
| Molecular Weight | 285.41 |
| Molecular Formula | C17H21N3S1 |
| Canonical SMILES | CN(C)C1=CC2=C(C=C1)NC3=C(S2)C=C(C=C3)N(C)C |